280 related articles for article (PubMed ID: 31091047)
21. Attitudes towards use of anabolic-androgenic steroids among Ghanaian high school students.
Sagoe D; Torsheim T; Molde H; Andreassen CS; Pallesen S
Int J Drug Policy; 2015 Feb; 26(2):169-74. PubMed ID: 25465347
[TBL] [Abstract][Full Text] [Related]
22. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
Velema MS; Kwa BH; de Ronde W
Curr Opin Pulm Med; 2012 Mar; 18(2):118-24. PubMed ID: 22189453
[TBL] [Abstract][Full Text] [Related]
23. Use of anabolic-androgenic steroids among body builders--frequency and attitudes.
Lindström M; Nilsson AL; Katzman PL; Janzon L; Dymling JF
J Intern Med; 1990 Jun; 227(6):407-11. PubMed ID: 2351927
[TBL] [Abstract][Full Text] [Related]
24. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
Piacentino D; Kotzalidis GD; Del Casale A; Aromatario MR; Pomara C; Girardi P; Sani G
Curr Neuropharmacol; 2015 Jan; 13(1):101-21. PubMed ID: 26074746
[TBL] [Abstract][Full Text] [Related]
25. Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study.
Buhl LF; Lehmann Christensen L; Diederichsen A; Lindholt JS; Kistorp CM; Glintborg D; Andersen M; Frystyk J
BMJ Open; 2024 May; 14(5):e078558. PubMed ID: 38719280
[TBL] [Abstract][Full Text] [Related]
26. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.
Piacentino D; Sani G; Kotzalidis GD; Cappelletti S; Longo L; Rizzato S; Fabi F; Frati P; Fineschi V; Leggio L
Hum Psychopharmacol; 2022 Jan; 37(1):e2815. PubMed ID: 34528289
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids.
Smith DA; Perry PJ
Ann Pharmacother; 1992 Apr; 26(4):520-8. PubMed ID: 1533554
[TBL] [Abstract][Full Text] [Related]
28. The use of steroids by gym athletes: an attempt to diagnose the problem scale and possible causes.
Gwizdek K; Brzęk A; Bąk-Sosnowska M; Dittfeld A; Knapik A; Ziaja D
J Sports Med Phys Fitness; 2018 Jun; 58(6):880-888. PubMed ID: 28597613
[TBL] [Abstract][Full Text] [Related]
29. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.
Bailey K; Yazdi T; Masharani U; Tyrrell B; Butch A; Schaufele F
PLoS One; 2016; 11(3):e0151860. PubMed ID: 26998755
[TBL] [Abstract][Full Text] [Related]
30. A qualitative assessment of anabolic-androgenic steroid use among gym users in Jordan: motives, perception, and safety.
Izzat N; Abu-Farha R; Harahsheh MM; Thiab S
Int J Legal Med; 2023 Sep; 137(5):1421-1430. PubMed ID: 37355480
[TBL] [Abstract][Full Text] [Related]
31. Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: A community based survey in Riyadh, Saudi Arabia.
Alharbi FF; Gamaleddin I; Alharbi SF; Almodayfer O; Allohidan F; Alghobain M; Arafah A; Al-Surimi K
Saudi Pharm J; 2019 Feb; 27(2):254-263. PubMed ID: 30766438
[TBL] [Abstract][Full Text] [Related]
32. Side effects of anabolic steroids used by athletes at Unaizah Gyms, Saudi Arabia: a pilot study.
Almaiman AA; Almaiman SH; Elagamy EI; Al Wutayd O; Almarzuqi M; Alzunaidi R; Alhatlani S; Eid EE
J Sports Med Phys Fitness; 2019 Mar; 59(3):489-495. PubMed ID: 29687691
[TBL] [Abstract][Full Text] [Related]
33. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
35. Anabolic androgenic steroids: a survey of 500 users.
Parkinson AB; Evans NA
Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
[TBL] [Abstract][Full Text] [Related]
36. Anabolic androgenic steroid abuse in the United Kingdom: An update.
Mullen C; Whalley BJ; Schifano F; Baker JS
Br J Pharmacol; 2020 May; 177(10):2180-2198. PubMed ID: 31989581
[TBL] [Abstract][Full Text] [Related]
37. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study.
Alsaeed I; Alabkal JR
Subst Abuse Treat Prev Policy; 2015 Aug; 10():33. PubMed ID: 26296560
[TBL] [Abstract][Full Text] [Related]
38. Human growth hormone abuse in male weightlifters.
Brennan BP; Kanayama G; Hudson JI; Pope HG
Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
[TBL] [Abstract][Full Text] [Related]
39. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors.
de Zeeuw TI; Brunt TM; van Amsterdam J; van de Ven K; van den Brink W
Eur Addict Res; 2023; 29(2):99-108. PubMed ID: 36731448
[TBL] [Abstract][Full Text] [Related]
40. What can allostasis tell us about anabolic-androgenic steroid addiction?
Hildebrandt T; Yehuda R; Alfano L
Dev Psychopathol; 2011 Aug; 23(3):907-19. PubMed ID: 21756441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
